002462.SHE Cachet Pharmaceutical Co Ltd
- Market cap
- CNY 3.13B
- P/E
- 214.4x
- P/B
- 0.72x
- ROE
- 1.4%
- Dividend yield
- 3.48%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 002462.SHE undervalued?
Graham number002462.SHE trades 161.3% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cachet Pharmaceutical Co Ltd fundamental analysis
No fundamental analysis for Cachet Pharmaceutical Co Ltd yet.
Cachet Pharmaceutical Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cachet Pharmaceutical Co Ltd
Cachet Pharmaceutical Co., Ltd. engages in the wholesale, retail, and logistics of pharmaceutical products in China. The company also offers medical drugs, medical devices, e-commerce products, and warehousing logistics services. It sells its products through online and offline channels. The company was founded in 1997 and is headquartered in Beijing, China.
Full company profileCachet Pharmaceutical Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cachet Pharmaceutical Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 11.0B | 14.2B | 18.0B | 22.2B | 23.3B | 25.6B | 26.2B | 30.0B | 24.0B | 19.5B | 16.2B |
| Gross Profit | 1.19B | 1.38B | 1.84B | 2.25B | 2.08B | 2.13B | 2.10B | 1.92B | 1.59B | 1.25B | 899M |
| Operating Income | 545M | 632M | 777M | 891M | 825M | 831M | 650M | 556M | 568M | 282M | 351M |
| EBITDA | 663M | 773M | 1.00B | 1.17B | 1.14B | 1.13B | 1.00B | 864M | 740M | 448M | 351M |
| Net Income | 223M | 264M | 328M | 376M | 318M | 354M | 297M | 250M | 161M | 111M | 59.9M |
| EPS | 0.89 | 1.05 | 1.31 | 1.44 | 1.09 | 1.21 | 1.02 | 0.86 | 0.55 | 0.38 | 0.21 |
| Balance Sheet | |||||||||||
| Total Assets | 7.38B | 9.20B | 10.9B | 13.0B | 14.1B | 14.9B | 16.6B | 17.1B | 14.0B | 12.7B | 10.8B |
| Total Liabilities | 4.44B | 6.01B | 7.12B | 8.11B | 8.81B | 9.28B | 10.6B | 11.0B | 7.97B | 6.87B | 5.02B |
| Shareholders' Equity | 1.98B | 2.21B | 2.50B | 3.43B | 3.63B | 3.89B | 4.08B | 4.24B | 4.33B | 4.35B | 4.36B |
| Cash & Short-term Investments | 796M | 1.12B | 1.08B | 1.58B | 2.02B | 2.34B | 2.18B | 2.89B | 2.22B | 2.56B | 2.27B |
| Total Debt | 1.70B | 2.81B | 3.33B | 3.46B | 3.78B | 4.00B | 4.28B | 4.02B | 2.75B | 1.80B | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 116M | -374M | -292M | 293M | 1.11B | 913M | -163M | 1.60B | 180M | 1.39B | - |
| Capital Expenditure | 38.9M | 21.3M | 21.7M | 263M | 258M | 247M | 189M | 199M | 15.4M | 22.8M | 15.9M |
| Free Cash Flow | 77.4M | -395M | -313M | 30.6M | 857M | 666M | -352M | 1.40B | 165M | 1.37B | 919M |
| Ratios | |||||||||||
| ROE | 11.3% | 11.9% | 13.1% | 11.0% | 8.8% | 9.1% | 7.3% | 5.9% | 3.7% | 2.6% | 1.4% |
| ROA | 3.0% | 2.9% | 3.0% | 2.9% | 2.2% | 2.4% | 1.8% | 1.5% | 1.1% | 0.9% | 0.6% |
| Net Profit Margin | 2.0% | 1.9% | 1.8% | 1.7% | 1.4% | 1.4% | 1.1% | 0.8% | 0.7% | 0.6% | 0.4% |
| Debt to Equity | 0.86x | 1.28x | 1.33x | 1.01x | 1.04x | 1.03x | 1.05x | 0.95x | 0.64x | 0.41x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cachet Pharmaceutical Co Ltd dividends
- Dividend yield
- 3.48%
- Forward dividend
- 0.12 CNY
- Payout ratio
- 97.7%
- Ex-dividend date
- Aug 28, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 109M | 0.37 | 97.7% |
| 2024 | CNY 168M | 0.57 | 104.3% |
| 2023 | CNY 214M | 0.74 | 85.7% |
| 2022 | CNY 108M | 0.37 | 36.3% |
| 2021 | CNY 96.3M | 0.33 | 27.2% |
| 2020 | CNY 117M | 0.40 | 36.7% |
| 2019 | CNY 37.6M | 0.14 | 10.0% |
| 2018 | CNY 224M | 0.89 | 68.3% |
| 2017 | CNY 121M | 0.48 | 46.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 15:10 on Jul 4, 2011.
Who owns Cachet Pharmaceutical Co Ltd
- Insiders 42.25%
- Institutions 0.13%
- Public & others 57.62%
- Shares outstanding 292M
- Free float 204M
Cachet Pharmaceutical Co Ltd company profile
- Company name
- Cachet Pharmaceutical Co Ltd
- Ticker
- 002462.SHE
- ISIN
- CNE100000SN0
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Aug 18, 2010
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 1,741
- Fiscal year end
- December
- Address
- Building 1, Beijing, China, 100195
- Phone
- 86 10 8846 0009
- Website
- cachet.com.cn
About Cachet Pharmaceutical Co Ltd
Cachet Pharmaceutical Co., Ltd. engages in the wholesale, retail, and logistics of pharmaceutical products in China. The company also offers medical drugs, medical devices, e-commerce products, and warehousing logistics services. It sells its products through online and offline channels. The company was founded in 1997 and is headquartered in Beijing, China.
Cachet Pharmaceutical Co Ltd management
5- Mr. Yibin HuangPresident & Non-Independent Director · born 1971
- Mr. Jun LinVP, Accounting Supervisor & Non-Independent Director · born 1969
- Mr. Hao ChaiAssistant to the President & Board Secretary · born 1976
- Mr. Wang PengVice President · born 1973
- Mr. Jiang WangSenior Expert · born 1966